Synthesis and antimicrobial evaluation of some novel 2-aminothiazole derivatives of 4-hydroxy-chromene-2-one

Archiv der Pharmazie

Volumn 341, Issue 8, 2008, Pages 491-496

  Vukovic, Nenad ^a   Sukdolak, Slobodan ^a   Solujic, Slavica ^a   Milosevic, Tanja ^a  

^a UNIVERSITY OF KRAGUJEVAC   (Serbia)

Author keywords

Antibacterial activity; Antifungal activity; Coumarin; Hantzsch reaction; Thiazole derivatives

Indexed keywords

2 AMINOTHIAZOLE DERIVATIVE; 2 HYDROXY 4 [4 (4 HYDROXY 2 OXO 2H CHROMEN 3 YL)THIAZOL 2 YLAMINO]BENZOIC ACID; 3 (2 DIETHYLAMINO THIAZOL 4 YL) 4 HYDROXYCHROMEN 2 ONE; 4 [4 (4 HYDROXY 2 OXO 2H CHROMEN 3 YL)THIAZOL 2 YLAMINO]BENZENESULFONIC ACID; 4 HYDROXY 3 (2 2 TOLYLAMINO THIAZOL 4 YL)CHROMEN 2 ONE; 4 HYDROXY 3 (2 3 TOLYLAMINO THIAZOL 4 YL)CHROMEN 2 ONE; 4 HYDROXY 3 [2 (3 NITROPHENYLAMINO)THIAZOL 4 YL]CHROMEN 2 ONE; 4 HYDROXY 3 [2 (4 NITRO PHENYLAMINO) THIAZOL 4 YL]CHROMEN 2 ONE; 4 HYDROXY 3 [2 (NAPHTHALEN 1 YLAMINO)THIAZOL 4 YL] 2H CHROMEN 2 ONE; 5 [4 (4 HYDROXY 2 OXO 2H CHROMEN 3 YL)THIAZOL 2 YLAMINO]PENTANOIC ACID; UNCLASSIFIED DRUG; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; BENZOPYRAN DERIVATIVE; THIAZOLE DERIVATIVE; THIOUREA;

ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG STRUCTURE; DRUG SYNTHESIS; INFRARED SPECTROSCOPY; NONHUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; CHEMISTRY; INFRARED SPECTROPHOTOMETRY; MICROBIOLOGICAL EXAMINATION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; STRUCTURE ACTIVITY RELATION; SYNTHESIS;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; ANTIFUNGAL AGENTS; BENZOPYRANS; MAGNETIC RESONANCE SPECTROSCOPY; MICROBIAL SENSITIVITY TESTS; SPECTROPHOTOMETRY, INFRARED; STRUCTURE-ACTIVITY RELATIONSHIP; THIAZOLES; THIOUREA;

EID: 53149139920     PISSN: 03656233     EISSN: 15214184     Source Type: Journal    
DOI: 10.1002/ardp.200700215     Document Type: Article

References (17)

1. R. D. H. Murray, J. Mendez, S. A. Brown, The Natural Coumarins, Wiley, New York, 1982.
2. J. L. R. Williams, D. P. Specht, S. Farid, Polym. Eng. Sci. 1983, 23, 1022-1024.
3. C. Spino, M. Dodier, S. Sotheeswaran, Bioorg. Med. Chem. Lett. 1998, 8, 3475-3478.
4. G. R. Madhavan, V. Balraju, B. Mallesham, R. Chakrabarti, V. B. Lohray, Bioorg. Med. Chem. Lett. 2003, 13, 2547-551.
5. C. Kontogiorgis, D. J. Hadjipavlou-Litina, J. Enzyme Inhib. Med. Chem. 2003, 18, 63-69.
6. J. R. S. Hoult, M. Paya, Gen. Pharmacol. 1996, 27, 713-722.
7. M. S. Y. Khan, P. Sharma, Indian J. Chem. 1993, 32, 817-821.
8. I. Kempen, D. Papapostolou, N. Thierry, L. Pochet, et al., Br. J. Cancer 2003, 88, 1111-1118.
9. R. B. J. Moffett, Med. Chem. 1964, 7, 446-449.
10. G. Redighiero, C. Antonello, Boll. Chim. Farm. 1958, 97, 592-601.
11. A. Mora, M. Paya, J. L. Rios, M. Alcaraz, Biochem. Pharmacol. 1990, 40, 793-797.
12. D. Lednicer, L. A. Mitscher, G. I. Georg, Organic Chemistry of Drug Synthesis, Wiley-Interscience Publication, John Wiley & Sons, Inc., New York, 1990, Vol. 4, pp. 95-97.
13. S. Rover, M. A. Cesura, P. Huguenin, A. Szente, J. Med. Chem. 1997, 40, 4378-4385.
14. K. S. Kim, S. D. Kimball, R. N. Misra, D. B. Rawlins, et al., J. Med. Chem. 2002, 45, 3905-3927.
15. Clinical and Laboratory Standards Institute, Performance Standards for Antimicrobial Susceptibility Testing; Fifteenth Informational Supplement, CLSI Document M100-S15, Clinical and Laboratory Standards Institute, Wayne, PA, 2005.
16. National Committee for Clinical Laboratory Standards, Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts. Approved Standards. NCCLS Document M27-A, National Committee for Clinical Laboratory Standards, Wayne, PA, 1997.
17. S. Sukdolak, S. Solujic, N. Manojlovic, N. Vukovic, L. Krstic, J. Heterocyclic Chem. 2004, 41, 593-596.